133 related articles for article (PubMed ID: 27806323)
1. Human sulfatase 1 exerts anti-tumor activity by inhibiting the AKT/ CDK4 signaling pathway in melanoma.
Lou X; Sun B; Song J; Wang Y; Jiang J; Xu Y; Ren Z; Su C
Oncotarget; 2016 Dec; 7(51):84486-84495. PubMed ID: 27806323
[TBL] [Abstract][Full Text] [Related]
2. Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model.
Xu G; Ji W; Su Y; Xu Y; Yan Y; Shen S; Li X; Sun B; Qian H; Chen L; Fu X; Wu M; Su C
Oncotarget; 2014 Jul; 5(13):5029-39. PubMed ID: 24970807
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
[TBL] [Abstract][Full Text] [Related]
4. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
[TBL] [Abstract][Full Text] [Related]
5. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
[TBL] [Abstract][Full Text] [Related]
6. HSULF-1 inhibits ERK and AKT signaling and decreases cell viability in vitro in human lung epithelial cells.
Zhang H; Newman DR; Sannes PL
Respir Res; 2012 Aug; 13(1):69. PubMed ID: 22873647
[TBL] [Abstract][Full Text] [Related]
7. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.
Li J; Mo ML; Chen Z; Yang J; Li QS; Wang DJ; Zhang H; Ye YJ; Li HL; Zhang F; Zhou HM
Cancer Sci; 2011 Oct; 102(10):1815-21. PubMed ID: 21722266
[TBL] [Abstract][Full Text] [Related]
8. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
[TBL] [Abstract][Full Text] [Related]
9. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
10. hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers.
Ji W; Yang J; Wang D; Cao L; Tan W; Qian H; Sun B; Qian Q; Yin Z; Wu M; Su C
PLoS One; 2011; 6(8):e23274. PubMed ID: 21853101
[TBL] [Abstract][Full Text] [Related]
11. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
12. Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer.
Li J; Kleeff J; Abiatari I; Kayed H; Giese NA; Felix K; Giese T; Büchler MW; Friess H
Mol Cancer; 2005 Apr; 4(1):14. PubMed ID: 15817123
[TBL] [Abstract][Full Text] [Related]
13. Hmgb1 inhibits Klotho expression and malignant phenotype in melanoma cells by activating NF-κB.
Xie B; Cao K; Li J; Chen J; Tang J; Chen X; Xia K; Zhou X; Cheng Y; Zhou J; Xie H
Oncotarget; 2016 Dec; 7(49):80765-80782. PubMed ID: 27779100
[TBL] [Abstract][Full Text] [Related]
14. P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells.
Hu H; Li Z; Chen J; Wang D; Ma J; Wang W; Li J; Wu H; Li L; Wu M; Qian Q; Chen J; Su C
Gut; 2011 May; 60(5):710-21. PubMed ID: 20971978
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
16. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
18. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma.
Lai JP; Chien J; Strome SE; Staub J; Montoya DP; Greene EL; Smith DI; Roberts LR; Shridhar V
Oncogene; 2004 Feb; 23(7):1439-47. PubMed ID: 14973553
[TBL] [Abstract][Full Text] [Related]
19. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
[TBL] [Abstract][Full Text] [Related]
20. Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer.
He X; Khurana A; Roy D; Kaufmann S; Shridhar V
Int J Cancer; 2014 Oct; 135(8):1783-9. PubMed ID: 24596063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
